Literature DB >> 7563110

Fibronectin expression during physiological and pathological cardiac growth.

F Farhadian1, F Contard, A Corbier, A Barrieux, L Rappaport, J L Samuel.   

Abstract

Fibronectin (FN) is a dimeric glycoprotein found in the extracellular matrix of most tissues that serves as a bridge between cells and the interstitial collagen meshwork and influences diverse processes including cell growth, adhesion, migration, and wound repair. Multiple FN forms arise by the alternative splicing of a primary transcript originating from a single gene. The spatial and temporal alterations in FN expression in the myocardium has been studied in models of cardiac growth in vivo such as fetal development, and hypertrophy secondary to pressure overload. This review focuses on the differential expression of FN isoforms that are observed in different models of cardiac growth. Using a combination of qualitative and quantitative analyses it is shown that in the rat myocardium: (1) the FN phenotype is developmentally regulated, (2) the re-expression of the fetal FN isoforms is observed in different models of cardiac hypertrophy secondary to a sudden or progressive hypertension and (3) the changes in cardiac FN expression affect mostly the coronary artery smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7563110     DOI: 10.1016/0022-2828(95)90067-5

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  27 in total

Review 1.  The extracellular matrix in normal and diseased myocardium.

Authors:  S Hein; J Schaper
Journal:  J Nucl Cardiol       Date:  2001 Mar-Apr       Impact factor: 5.952

2.  Cooperative coupling of cell-matrix and cell-cell adhesions in cardiac muscle.

Authors:  Megan L McCain; Hyungsuk Lee; Yvonne Aratyn-Schaus; André G Kléber; Kevin Kit Parker
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-06       Impact factor: 11.205

3.  The contribution of cellular mechanotransduction to cardiomyocyte form and function.

Authors:  Sean P Sheehy; Anna Grosberg; Kevin Kit Parker
Journal:  Biomech Model Mechanobiol       Date:  2012-07-07

4.  Mesenchymal stem cells ability to generate traction stress in response to substrate stiffness is modulated by the changing extracellular matrix composition of the heart during development.

Authors:  Joshua R Gershlak; Joshua I N Resnikoff; Kelly E Sullivan; Corin Williams; Raymond M Wang; Lauren D Black
Journal:  Biochem Biophys Res Commun       Date:  2013-08-30       Impact factor: 3.575

5.  The extracellular matrix in hibernating myocardium--a significant factor causing structural defects and cardiac dysfunction.

Authors:  A Elsässer; M Schlepper; R Zimmermann; K D Müller; R Strasser; W P Klövekorn; J Schaper
Journal:  Mol Cell Biochem       Date:  1998-09       Impact factor: 3.396

Review 6.  Mechanotransduction: the role of mechanical stress, myocyte shape, and cytoskeletal architecture on cardiac function.

Authors:  Megan L McCain; Kevin Kit Parker
Journal:  Pflugers Arch       Date:  2011-04-19       Impact factor: 3.657

7.  Disruption of integrin function in the murine myocardium leads to perinatal lethality, fibrosis, and abnormal cardiac performance.

Authors:  R S Keller; S Y Shai; C J Babbitt; C G Pham; R J Solaro; M L Valencik; J C Loftus; R S Ross
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

8.  Young developmental age cardiac extracellular matrix promotes the expansion of neonatal cardiomyocytes in vitro.

Authors:  C Williams; K P Quinn; I Georgakoudi; L D Black
Journal:  Acta Biomater       Date:  2013-09-06       Impact factor: 8.947

9.  Detection of type III collagen fragments in specimens of abdominal aortic aneurysms.

Authors:  T Kuga; K Esato; N Zempo; K Fujioka; K Nakamura
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

Review 10.  Intramyocardial fibroblast myocyte communication.

Authors:  Rahul Kakkar; Richard T Lee
Journal:  Circ Res       Date:  2010-01-08       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.